Literature DB >> 7023947

Long-term treatment of congestive heart failure by captopril: hemodynamic, biological and clinical effects.

J G Kayanakis, J M Fauvel, P Giraud, J P Bounhoure.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7023947     DOI: 10.1093/oxfordjournals.eurheartj.a061166

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

1.  Factors predicting acute and long-term response to captopril therapy in congestive heart failure.

Authors:  T B Levine; J N Cohn
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 2.  The treatment of heart failure. A methodological review of the literature.

Authors:  G H Guyatt
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

3.  Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.

Authors:  P M Schofield; N H Brooks; G P Lawrence; H J Testa; C Ward
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

4.  Acute and long-term response to enalapril in congestive failure.

Authors:  J K Kjekshus; E Søyland; K Dickstein; A M Abrahamsen; T Gundersen
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 5.  Angiotensin inhibitors and other vasodilators with special reference to congestive heart failure.

Authors:  K Chatterjee; L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

6.  Long-term captopril therapy in severe refractory congestive heart failure.

Authors:  L Steingo; W A Pocock; H Flax; M Stein; J B Barlow
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 7.  Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.

Authors:  J A Romankiewicz; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.